An Open-Label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium I.V. (Esomeprazole Sodium) 40mg BID for up to 72 Hours.

Trial Profile

An Open-Label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium I.V. (Esomeprazole Sodium) 40mg BID for up to 72 Hours.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Jan 2011

At a glance

  • Drugs Esomeprazole (Primary)
  • Indications Hyperchlorhydria
  • Focus Pharmacodynamics
  • Sponsors AstraZeneca
  • Most Recent Events

    • 21 Jan 2011 Actual end date (Nov 2006) added as reported by ClinicalTrials.gov.
    • 24 Jul 2007 Status changed from recruiting to in progress.
    • 03 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top